Trials / Unknown
UnknownNCT02571699
Minimum Effective Volume of Lidocaine-Bupivacaine for Subgluteal Block
Minimum Effective Volume of Lidocaine-Bupivacaine for Ultrasound-Guided Subgluteal Sciatic Nerve Block
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to determine the minimum effective volume of LA in 90 % of patients (MEV90) required for US-guided subgluteal sciatic nerve block.
Detailed description
The aim of this study is to determine the minimum effective volume of LA in 90 % of patients (MEV90) required for US-guided subgluteal sciatic nerve block. Success rate is defined as a minimal composite score of 6 points (out of 8 points) at 30 minutes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Subgluteal Nerve Block | ultrasound-guided subgluteal sciatic nerve block. |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2015-10-08
- Last updated
- 2016-06-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02571699. Inclusion in this directory is not an endorsement.